Back to search
FDAFDA · Food and drugs·Recall number D-1549-2022

Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 16110-080-45

Published October 5, 2022 · Recall initiated: September 16, 2022

Summary

FDA records drug Class III recall D-1549-2022, published October 5, 2022 and initiated September 16, 2022. Recalling firm: ALMIRALL, LLC; Status: Terminated; Reported quantity: 5,315 tubes; Lot: Lot #: RGAF, Exp. Date 12/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Viscosity specification: Slightly higher OOS results obtained for viscosity

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ALMIRALL, LLC
Distributor
Nationwide within the United States
Lot
Lot #: RGAF, Exp. Date 12/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 16110-080-45 recalled?

Yes. FDA published recall D-1549-2022 on October 5, 2022. Reported hazard: Failed Viscosity specification: Slightly higher OOS results obtained for viscosity

What should I do if I have this product?

Voluntary: Firm initiated · Letter